Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoxetine for breath-holding spells in children
IRCT20161230031668N3Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of fluoxetine in Breath-holding spell (BHS) (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoint: Number of breath-holding spells in a month. Started Jun 2018; status: completed.
02
Drugs
fluoxetine
03
Conditions
Breath-holding spell (BHS)
Beyond the preview
Go deeper on IRCT20161230031668N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20161230031668N3.